Menu
GWAS Study

Identification of nine new susceptibility loci for endometrial cancer.

O'Mara TA, Glubb DM, Amant F et al.

30093612 PubMed ID
GWAS Study Type
54884 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

OT
O'Mara TA
GD
Glubb DM
AF
Amant F
AD
Annibali D
AK
Ashton K
AJ
Attia J
AP
Auer PL
BM
Beckmann MW
BA
Black A
BM
Bolla MK
BH
Brauch H
BH
Brenner H
BL
Brinton L
BD
Buchanan DD
BB
Burwinkel B
CJ
Chang-Claude J
CS
Chanock SJ
CC
Chen C
CM
Chen MM
CT
Cheng THT
CC
Clarke CL
CM
Clendenning M
CL
Cook LS
CF
Couch FJ
CA
Cox A
CM
Crous-Bous M
CK
Czene K
DF
Day F
DJ
Dennis J
DJ
Depreeuw J
DJ
Doherty JA
DT
Dörk T
DS
Dowdy SC
DM
Dürst M
EA
Ekici AB
FP
Fasching PA
FB
Fridley BL
FC
Friedenreich CM
FL
Fritschi L
FJ
Fung J
GM
García-Closas M
GM
Gaudet MM
GG
Giles GG
GE
Goode EL
GM
Gorman M
HC
Haiman CA
HP
Hall P
HS
Hankison SE
HC
Healey CS
HA
Hein A
HP
Hillemanns P
HS
Hodgson S
HE
Hoivik EA
HE
Holliday EG
HJ
Hopper JL
HD
Hunter DJ
JA
Jones A
KC
Krakstad C
KV
Kristensen VN
LD
Lambrechts D
ML
Marchand LL
LX
Liang X
LA
Lindblom A
LJ
Lissowska J
LJ
Long J
LL
Lu L
MA
Magliocco AM
ML
Martin L
MM
McEvoy M
MA
Meindl A
MK
Michailidou K
MR
Milne RL
MM
Mints M
MG
Montgomery GW
NR
Nassir R
OH
Olsson H
OI
Orlow I
OG
Otton G
PC
Palles C
PJ
Perry JRB
PJ
Peto J
PL
Pooler L
PJ
Prescott J
PT
Proietto T
RT
Rebbeck TR
RH
Risch HA
RP
Rogers PAW
RM
Rübner M
RI
Runnebaum I
SC
Sacerdote C
SG
Sarto GE
SF
Schumacher F
SR
Scott RJ
SV
Setiawan VW
SM
Shah M
SX
Sheng X
SX
Shu XO
SM
Southey MC
SA
Swerdlow AJ
TE
Tham E
TJ
Trovik J
TC
Turman C
TJ
Tyrer JP
VC
Vachon C
VB
VanDen Berg D
VA
Vanderstichele A
WZ
Wang Z
WP
Webb PM
WN
Wentzensen N
WH
Werner HMJ
WS
Winham SJ
WA
Wolk A
XL
Xia L
XY
Xiang YB
YH
Yang HP
YH
Yu H
ZW
Zheng W
PP
Pharoah PDP
DA
Dunning AM
KP
Kraft P
DV
De Vivo I
TI
Tomlinson I
ED
Easton DF
SA
Spurdle AB
TD
Thompson DJ
Chapter II

Abstract

Summary of the research findings

Endometrial cancer is the most commonly diagnosed cancer of the female reproductive tract in developed countries. Through genome-wide association studies (GWAS), we have previously identified eight risk loci for endometrial cancer. Here, we present an expanded meta-analysis of 12,906 endometrial cancer cases and 108,979 controls (including new genotype data for 5624 cases) and identify nine novel genome-wide significant loci, including a locus on 12q24.12 previously identified by meta-GWAS of endometrial and colorectal cancer. At five loci, expression quantitative trait locus (eQTL) analyses identify candidate causal genes; risk alleles at two of these loci associate with decreased expression of genes, which encode negative regulators of oncogenic signal transduction proteins (SH2B3 (12q24.12) and NF1 (17q11.2)). In summary, this study has doubled the number of known endometrial cancer risk loci and revealed candidate causal genes for future study.

8,758 European ancestry cases, 46,126 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

54884
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
U.S., Australia, Belgium, Germany, Norway, Sweden, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.